Rodriguez-Vida A, Maroto P, Font A, Martin C, et al. Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study. Br J Cancer 2022 Oct 26. pii: 10.1038/s41416-022-01991.
PMID: 36289372